Where does Fresenius Hemocare Italia S.R.L. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Fresenius Hemocare Italia S.R.L. ranks #40,296 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Fresenius Hemocare Italia S.R.L. hold?

Fresenius Hemocare Italia S.R.L. holds 6 US utility patents granted between 2018 and 2025, spanning 5 technology areas.

What is Fresenius Hemocare Italia S.R.L.'s Innovation Score?

Fresenius Hemocare Italia S.R.L. has an Innovation Score of 39.5 out of 100 (top 38% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Fresenius Hemocare Italia S.R.L.'s patent grant rate increasing or decreasing?

Fresenius Hemocare Italia S.R.L.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Fresenius Hemocare Italia S.R.L.'s patents?

Fresenius Hemocare Italia S.R.L.'s patents average 19.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Fresenius Hemocare Italia S.R.L. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Fresenius Hemocare Italia S.R.L.

Q: What technology areas does Fresenius Hemocare Italia S.R.L. focus on?

Fresenius Hemocare Italia S.R.L.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 6 patents, ranking #1,115 of 3,490 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Fresenius ranks #40,296 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 5 technology areas.

#40,296
of 49,997 US assignees by volume: Top 38%
by Innovation Score (39.5/100): 19.2
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R40296 · Foreign Corporation #40,296 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #40,296/49,997
PHOTO-FINISH Fraunhofer Portugal…
CPC-NARROW A61M · 5 areas
INNOV-THIN 39.5/100
CLAIMS-RICH 19.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Fraunhofer Portugal Research (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Fresenius’s 39.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (17%) Velocity 13.3 pts (34%) Breadth 7.9 pts (20%) Claim depth 11.5 pts (29%)

Qualcomm Incorporated · highest

85
Fresenius Hemocare… · this assignee

39
3D Lighting… · lowest

7

What this shows Fresenius's Innovation Score is 39.5/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Fresenius?

Each dot is one of Fresenius’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Fresenius’s own 19.2 claims/patent is ABOVE the 16.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Fresenius vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Fresenius's grants concentrate

Fresenius Hemocare Italia S.R.L. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). By volume, Fresenius sits between Fraunhofer Portugal Research and Fujian JXD Technology Co., Ltd..

Fresenius's three-year grant acceleration

Fresenius Hemocare Italia S.R.L. shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Fraunhofer Portug…

6
Fred Herz Patents

6
Freeus

6
Fremont Micro Dev…

6
Friedrich Lütze

6
Frog Creek Partne…

6
Frugalpac

6
Fujian JXD Techno…

6
Fresenius Hemocar… ◀

6

What this shows Fresenius holds 6 patents at rank #40,314, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Fresenius

By rank, the assignees closest to #40,314 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Fresenius's primary technology class.

Fresenius's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 38% higher than 62% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Fresenius Hemocare Italia S.R.L. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	16.7%
2019	1	16.7%
2022	1	16.7%
2023	1	16.7%
2025partial year	2	33.3%

Which technologies does Fresenius Hemocare Italia S.R.L. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 6

B01D - Separation 6

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Fresenius Hemocare Italia S.R.L.'s patent record in context - here's where to go next.

Fresenius Hemocare Italia S.R.L.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 100% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #40,296 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Fresenius Hemocare Italia S.R.L. against Fraunhofer Portugal Research, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.